This inventor holds 2 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 1991.
Company Filing History:
Years Active: 1991
Title: The Innovations of Ronald Mink
Introduction
Ronald Mink is an accomplished inventor based in Wilbraham, MA (US). He has made significant contributions to the field of immunology through his innovative work on monoclonal antibodies. With a total of 2 patents, his inventions have the potential to enhance diagnostic methods in the medical field.
Latest Patents
Mink's latest patents include groundbreaking developments in hybridoma cell lines and monoclonal antibodies targeting Treponema species. One of his notable patents is for a monoclonal antibody to Treponema denticola JD-1 and Treponema species 10A, along with a continuous cell line for its production. These antibodies are particularly useful in immunoassays for detecting the presence of these microorganisms in the oral cavity. Another significant patent focuses on a monoclonal antibody to Treponema denticola ATCC 33520, also accompanied by a continuous cell line for its production. This invention further aids in the detection of these microorganisms in oral health diagnostics.
Career Highlights
Ronald Mink has been associated with Warner-Lambert Company, where he has applied his expertise in immunology to develop innovative solutions. His work has contributed to advancements in the detection of oral microorganisms, which is crucial for maintaining oral health.
Collaborations
Mink has collaborated with notable colleagues such as Dou-Mei Wang and Linda D Sturdivant. Their combined efforts have led to significant advancements in the field of immunology and diagnostics.
Conclusion
Ronald Mink's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the medical community, particularly in the area of oral health diagnostics.